http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009176310-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_45a53cd982044e68687f452fcfbc7132
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-56
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86
filingDate 2009-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d275e9ffe8157ad5016b9ca4a488536
publicationDate 2009-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2009176310-A1
titleOfInvention Detection procedures for fibrinogen and/or fibrinogen derivatives
abstract Described are determination procedures for fibrinogen and/or fibrinogen-derivatives by matrix-independent turbidimetry. In the FIFTA called procedure the fibrinogen activity is preferably determined in an undiluted sample by addition of thrombin and/or albumin, as well as polybrene if appropriate, in PBS and determination of the increase in absorbance at 405 nm. In the FIATA called procedure the fibrinogen-concentration and/or the concentration of fibrinogen-derivatives is preferably determined by addition of vancomycin and determination of the increase in turbidity at 405 nm. It is standardized by usage of plasma standards of known fibrinogen-activity and/or fibrinogen-concentration.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011057364-A1
priorityDate 2003-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6184027-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4692406-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5851836-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7510879-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6448024-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5292664-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6670177-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002168398-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5651
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395424
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395423
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23667548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129329937
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427933
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136230068
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395861
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8097
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128769907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54670067
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16051955
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3641960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31388
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136104873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25200375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11605666
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227750224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466

Total number of triples: 53.